Normally, when a company reports its quarterly results, investors are eager to find out how much revenue and earnings growth was achieved. But for GW Pharmaceuticals (NASDAQ: GWPH), those metrics are pretty much irrelevant.
The Only 2 Numbers in This Top Marijuana Stock's Q2 Results That Matter
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться